Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
5.78
-0.56 (-8.83%)
Mar 31, 2025, 1:43 PM EDT - Market open
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $290.30 million as of March 31, 2025. Its market cap has decreased by -25.59% in one year.
Market Cap
290.30M
Enterprise Value
157.22M
1-Year Change
-25.59%
Ranking
Category
Stock Price
$5.78
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has decreased from $397.73M to $290.30M, a decrease of -27.01%. That is a compound annual growth rate of -8.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 318.43M | -22.45% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |